CEBPA Model Recreates RTK–RAS Leukemic Evolution

Evidence Rolling-window publication catch-up · Peer-Reviewed September 4, 2026 · Discovery September 7, 2026 · Importance 4/5 · Direction Uncertain Summary University of Cambridge and Wellcome Sanger Institute researchers reported an immunocompetent, stepwise model of myeloid-neoplasm evolution. A patient-derived CEBPA N321D mutation created a long-lived…